{Reference Type}: Review
{Title}: Diagnostic imaging of salivary gland cancers: REFCOR recommendations by the formal consensus method.
{Author}: Varoquaux A;Fakhry N;Baujat B;Verillaud B;Jegoux F;Barry B;Chabrillac E;Vergez S;Terroir-Cassou-Mounat M;
{Journal}: Eur Ann Otorhinolaryngol Head Neck Dis
{Volume}: 141
{Issue}: 1
{Year}: 2024 Jan 29
{Factor}: 2.665
{DOI}: 10.1016/j.anorl.2023.11.007
{Abstract}: <B>OBJECTIVE: </B>To define the indications for each imaging modality in the screening, characterization, extension and follow-up of salivary gland tumors.<BR><B>METHODS: </B>The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group who drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.<BR><B>RESULTS: </B>If a swelling of a salivary gland is palpable for 3 weeks, an ultrasound scan is recommended to confirm a tumoral lesion and rule out differential diagnoses. For a salivary gland tumor, MRI is recommended with diffusion-weighted and dynamic contrast-enhanced techniques. In the case of histologically proven malignancy or a highly suspicious lesion, a CT scan of the neck and chest is recommended to assess the tumor, lymph nodes and metastases. FDG-PET is not currently recommended in routine clinical practice for initial diagnosis, assessment of extension, evaluation of response to treatment, staging of recurrence, or follow-up of salivary gland tumors.<BR><B>CONCLUSIONS: </B>Assessing salivary tumors is based on MRI. Extension assessment is based on neck and chest CT.